MICB and neoplasm: Vorinostat downregulated microRNA-20a, diminished STAT3 tyrosine phosphorylation, and increased histone acetylation at MICA and MICB promoters, leading to increased expression of these genes and enhanced natural killer (NK) cell-mediated tumor targeting [90].